Ferring Pharmaceuticals, Inc.
Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer
- First Posted Date
- 2014-09-01
- Last Posted Date
- 2017-11-27
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 112
- Registration Number
- NCT02229253
- Locations
- 🇳🇱
Groene Hart Ziekenhuis (there may be other sites in this country), Gouda, Netherlands
A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing
- Conditions
- Colon Cleansing in Preparation for Colonoscopy
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 637
- Registration Number
- NCT02215954
- Locations
- 🇯🇵
Investigational site, Tokyo, Japan
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
- Conditions
- Crohn's Disease
- Interventions
- Other: This study will evaluate a new clinical scoring system in patients receiving routine treatment
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 216
- Registration Number
- NCT02193048
- Locations
- 🇩🇪
Investigational site (there may be other sites in this country), Altenholz, Germany
A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency
- Conditions
- Idiopathic Growth Hormone Deficiency
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 23
- Registration Number
- NCT02173821
- Locations
- 🇮🇳
Seth GSMC & KEM Hospital (there may be other sites in this country), Maharashtra, India
🇷🇴Paediatric Endocrinology/Medicali's SRL (there may be other sites in this country), Timisoara, Romania
🇭🇺Szent János Kórház és Észak Budai Egyesített Kórházai (there may be other sites in this country), Budapest, Hungary
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2017-10-26
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 160
- Registration Number
- NCT02149264
- Locations
- 🇺🇸
Investigational site, Norfolk, Virginia, United States
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 3
- Registration Number
- NCT02018172
- Locations
- 🇫🇷
Hôpital des Enfants, CHU de Toulouse, Toulouse, France
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 738
- Registration Number
- NCT02018159
- Locations
- 🇩🇰
Fertilitetsklinikken Hospitalsenheden Horsens, Regionshospitalet Horsens (there may be other sites in this country), Horsens, Denmark
An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 206
- Registration Number
- NCT02015871
- Locations
- 🇨🇳
Peking University People's Hospital (there may be multiple sites in this country), Beijing, Beijing, China
LutrePulse Hypogonadotropic Hypogonadism
- Conditions
- Primary Amenorrhea With Hypogonadotropic Hypogonadism
- Interventions
- Drug: Placebo (SC 10, 15, or 20 μg/pulse as a fixed dose, administered via. OmniPod pump)
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 39
- Registration Number
- NCT01976728
- Locations
- 🇺🇸
Wayne State University Physicians Group, Southfield, Michigan, United States
🇺🇸Fertility Treatment Center, Tempe, Arizona, United States
🇺🇸Maine Medical Center-REI, Portland, Maine, United States
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
- Conditions
- Hyperphagia in Prader-Willi Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 38
- Registration Number
- NCT01968187
- Locations
- 🇺🇸
Florida University, Gainesville, Florida, United States
🇺🇸Winthrop University, Mineola, New York, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States